[{"Assets_0_Q2_USD":"1578300000.0","CIK":"899923","CommonStockSharesIssued_0_Q2_shares":"74500000.0","CommonStockSharesOutstanding_0_Q2_shares":"74500000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.11","EarningsPerShareBasic_2_Q2_USD":"-0.39","EarningsPerShareDiluted_1_Q2_USD":"-0.11","EarningsPerShareDiluted_2_Q2_USD":"-0.39","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q2_USD":"100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"13900000.0","NetIncomeLoss_1_Q2_USD":"-8300000.0","NetIncomeLoss_2_Q2_USD":"-28900000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q2_USD":"-8300000.0","ProfitLoss_2_Q2_USD":"-28900000.0","RevenuesConverted_1_Q2_USD":"195100000.0","RevenuesConverted_2_Q2_USD":"381400000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"1077300000.0","StockholdersEquity_0_Q2_USD":"1077200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"74400000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"74100000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"74400000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"74100000.0","filed":"20200207","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"MYRIAD GENETICS INC","period":"20191231","qtrs":"0","uom":"USD"}]